Literature DB >> 22833762

Blindness and visual impairment in Germany: a slight fall in prevalence.

Robert P Finger1, Bernd Bertram, Christian Wolfram, Frank G Holz.   

Abstract

BACKGROUND: Some 70% of all cases of blindness in Germany are due to diseases of old age. As the population at large is aging, the prevalence of blindness and visual impairment would be expected to rise. To assess this, we studied prevalence trends in Germany over the past three decades.
METHODS: We calculated the age- and sex-standardized prevalence of blindness in Germany using data from the archive of the blind registry of the Rhineland Regional Council (Landschaftsverband Rheinland, LVR) for the years 1978 to 2006. We then validated the findings with the aid of data on blindness and visual impairment from the Statistics on Severe Disability (Schwerbehindertenstatistik, SBS) that are published periodically by the German Federal Statistical Office.
RESULTS: The number of registered blind persons in the Rhineland increased from 10,665 in 1978 to 12,706 in 1987 and 15,766 in 1997, but it changed little thereafter, remaining at 15,725 in 2006. There was a corresponding trend in the prevalence of blindness in the Rhineland, which rose from 116.8 to 165.6 per 100,000 persons from 1978 to 1997 but was roughly the same, at 163.1 per 100,000 persons, in 2006. The SBS data on blindness and visual impairment reveal a decline in prevalence from 392 to 372 per 100,000 persons between 1987 and 2005. The standardized prevalence rates for blindness and visual impairment in Germany have been declining slowly since about 1997. DISCUSSION: Blindness and visual impairment have become slightly less common in Germany, even though the population is aging. This may be due, at least in part, to better eye health care.

Entities:  

Mesh:

Year:  2012        PMID: 22833762      PMCID: PMC3402073          DOI: 10.3238/arztebl.2012.0484

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  21 in total

1.  Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010.

Authors:  Sara Brandi Bloch; Michael Larsen; Inger Christine Munch
Journal:  Am J Ophthalmol       Date:  2012-02       Impact factor: 5.258

2.  Blindness and low vision in Germany 1993-2009.

Authors:  Christian Wolfram; Norbert Pfeiffer
Journal:  Ophthalmic Epidemiol       Date:  2012-02       Impact factor: 1.648

3.  Time trends in the incidence and causes of blindness in Israel.

Authors:  Alon Skaat; Angela Chetrit; Michael Belkin; Michael Kinori; Ofra Kalter-Leibovici
Journal:  Am J Ophthalmol       Date:  2012-02       Impact factor: 5.258

4.  Incidence of blindness and severe visual impairment in Germany: projections for 2030.

Authors:  Robert P Finger; Rolf Fimmers; Frank G Holz; Hendrik P N Scholl
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-21       Impact factor: 4.799

5.  High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000.

Authors:  W Rathmann; B Haastert; A Icks; H Löwel; C Meisinger; R Holle; G Giani
Journal:  Diabetologia       Date:  2003-02-18       Impact factor: 10.122

6.  Prevalence and causes of registered blindness in the largest federal state of Germany.

Authors:  Robert P Finger; Rolf Fimmers; Frank G Holz; Hendrik P N Scholl
Journal:  Br J Ophthalmol       Date:  2011-03-03       Impact factor: 4.638

7.  Projected number of Australians with visual impairment in 2000 and 2030.

Authors:  S Foran; J J Wang; E Rochtchina; P Mitchell
Journal:  Clin Exp Ophthalmol       Date:  2000-06       Impact factor: 4.207

8.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

9.  Birth cohort effect on prevalence of age-related maculopathy in the Beaver Dam Eye Study.

Authors:  Guan-Hua Huang; Ronald Klein; Barbara E K Klein; Sandra C Tomany
Journal:  Am J Epidemiol       Date:  2003-04-15       Impact factor: 4.897

10.  National Registry for the Blind in Israel: estimation of prevalence and incidence rates and causes of blindness.

Authors:  Marilyn D Farber
Journal:  Ophthalmic Epidemiol       Date:  2003-10       Impact factor: 1.648

View more
  18 in total

1.  [National guidelines for treatment of diabetic retinopathy : Second edition of the national guidelines for treatment of diabetic retinopathy].

Authors:  F Ziemssen; K Lemmen; B Bertram; H P Hammes; H Agostini
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

2.  [Requirements for low vision magnification aids in age-related macular degeneration: Data from the Tübingen low vision clinic (comparison of 2007-2011 with 1999-2005)].

Authors:  E K Altpeter; N X Nguyen
Journal:  Ophthalmologe       Date:  2015-11       Impact factor: 1.059

Review 3.  [Ophthalmology 2019-where do we stand? : An analysis of the treatment situation in Germany].

Authors:  Alexander K Schuster; Christian Wolfram; Norbert Pfeiffer; Robert P Finger
Journal:  Ophthalmologe       Date:  2019-09       Impact factor: 1.059

4.  [Trends in inpatient treatment in ophthalmology in Germany].

Authors:  R P Finger; J Köberlein-Neu; P Gass; F G Holz; B Bertram
Journal:  Ophthalmologe       Date:  2013-03       Impact factor: 1.059

5.  [Epidemiology of severe visual impairment and blindness of old people in Germany].

Authors:  M M Mauschitz; J Q Li; P P Larsen; J Köberlein-Neu; F G Holz; M M B Breteler; R P Finger
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

6.  The Prevalence of Visual Impairment in the Adult Population.

Authors:  Christian Wolfram; Alexander K Schuster; Heike M Elflein; Stefan Nickels; Andreas Schulz; Philipp S Wild; Manfred E Beutel; Maria Blettner; Thomas Münzel; Karl J Lackner; Norbert Pfeiffer
Journal:  Dtsch Arztebl Int       Date:  2019-04-26       Impact factor: 5.594

7.  Optimal treatment of diabetic retinopathy.

Authors:  Hans-Peter Hammes
Journal:  Ther Adv Endocrinol Metab       Date:  2013-04       Impact factor: 3.565

8.  [Design of the ORCA module in the OCEAN study : Evaluation of SD-OCT results in daily routine practice].

Authors:  B Heimes; T Schick; C K Brinkmann; A Wiedon; B Haegele; B Kirchhof; F G Holz; D Pauleikhoff; F Ziemssen; S Liakopoulos; G Spital; S Schmitz-Valckenberg
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

Review 9.  The Diagnosis and Treatment of Age-Related Macular Degeneration.

Authors:  Andreas Stahl
Journal:  Dtsch Arztebl Int       Date:  2020-07-20       Impact factor: 5.594

10.  [Increase in examinations for cataracts, glaucoma, diabetic retinopathy and age-related macular degeneration : Comparative cross-sectional study between 2010 and 1997 in ophthalmological practices].

Authors:  B Bertram; C Gante; R-D Hilgers
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.